{
    "Variants Include": [
        {
            "Gene": "a - synuclein",
            "variants": [
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P point mutation"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Description in input context": "A53T point mutation"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0005149"
    },
    "Experiment Method": [
        {
            "Assay Method": "cDNA cloning, cell culture and transfection and RT - PCR",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "human neuroblastoma M17 cells",
                "Description": "Human neuroblastoma M17 cells were cultured in Ham's F - 12 high glucose Dulbecco's modified Eagle's medium containing Eagle's Minimum Essential Medium supplemented with 10% fetal bovine serum, L - glutamine, non - essential amino acids, sodium pyruvate and penicillin - streptomycin."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Increased HO - 1 expression suppresses intracellular a - synuclein levels. In cells transfected with 4, 8 and 12 μg HO - 1, the amounts of a - synuclein protein were, respectively, 16.1%, 39.5% and 47.3% lower relative to sham - transfected cells. A significant inverse correlation was observed between levels of transgenic HO - 1 and a - synuclein expression in these cells. HO - 1 over - expression does not reduce a - synuclein protein by reducing a - synuclein mRNA levels in M17 cells."
                },
                {
                    "Variant": "A30P",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Myc - a - synuclein (A30P) displayed remarkable resistance to HO - 1 - induced proteosomal degradation. In cells transfected with 4, 8 and 12 μg of HO - 1, Myc - a - synuclein (A30P) levels were 95%, 105% and 110% respectively, of basal level observed in cells expressing Myc - a - synuclein (A30P) alone. Suppression of HO - 1 over - expression restored Myc - a - synuclein (WT) levels without affecting the concentration of Myc - a - synuclein (A30P)."
                },
                {
                    "Variant": "A53T",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "In cells over - expressing HO - 1, the amount of A53T was 10.8% of those expressing mock construct. A53T mutation did not affect a - synuclein degradation significantly in HO - 1 over - expressing cells."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "The data were presented as mean ± SE. Statistical analyses were performed by one - way ANOVA followed by Newman - Keuls post hoc comparisons to assess significant main effects within groups. Statistical significance was set at p < 0.05."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "HO - 1 gene silencing",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "M17 cells",
                "Description": "The HO - 1 gene was silenced in M17 cells essentially as described previously. siRNA motif against human HO - 1 was selected according to the rule of amino acid Asn - 19 targeting 106 - 126 nucleotides downstream of the start codon based on human HO - 1 cDNA sequence."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Reducing the expression of transgenic HO - 1 restored intracellular a - synuclein levels. HO - 1 over - expressing cells transfected with pSuper - Retro - siHO - 1 had a 72% decrease in HO - 1 over - expression with a concomitant three - fold increase in a - synuclein levels and a 3.5 - fold increase in tau levels."
                },
                {
                    "Variant": "A30P",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Suppression of HO - 1 over - expression by siRNA in HO - 1 - transfected cells with Myc - A30P did not affect the concentration of Myc - a - synuclein (A30P) despite a 70% reduction in HO - 1 protein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "The data were presented as mean ± SE. Statistical analyses were performed by one - way ANOVA followed by Newman - Keuls post hoc comparisons to assess significant main effects within groups. Statistical significance was set at p < 0.05."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "HO enzyme activity assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "Cells (not specified cell line)",
                "Description": "Cells were lysed in 20 mM Tris - HCl (pH 7.4) containing 0.25 M sucrose and protease inhibitor cocktail, sonicated on ice and centrifuged for 20 min at 4°C at 15 000 g. The reaction was initiated by adding an aliquot of the supernatant into the vial containing the rest of the components of the assay mixture."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Mock - transfected cells exhibited low levels of basal HO activity which was likely because of cellular HO - 2. HO - 1 - transfected cells displayed HO activity that was 2.8 - fold higher than basal levels. Cells transfected with HO - 1 and treated with SnMP exhibited similar amounts of HO - 1 protein but displayed HO activity only slightly above basal levels. Inhibition of HO activity by SnMP completely abrogated the decline in cellular a - synuclein levels accruing from over - expression of the HO - 1 transgene."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "The data were presented as mean ± SE. Statistical analyses were performed by one - way ANOVA followed by Newman - Keuls post hoc comparisons to assess significant main effects within groups. Statistical significance was set at p < 0.05."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "a - Synuclein aggregation assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "Cells transfected with different combinations of HO - 1, a - synuclein (WT) and a - synuclein (A30P)",
                "Description": "Cells transfected with different combinations of HO - 1, a - synuclein (WT) and a - synuclein (A30P) for 48 h were lysed in lysis buffer and centrifuged for 30 min at 15 000 g. The pellet was discarded and the protein concentration of each sample was adjusted to 1 mg/mL using lysis buffer."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "N.D.",
                    "Result Description": "HO - 1 significantly reduced aggregation of a - synuclein (WT) but not that of A30P. The relative amount of aggregated a - synuclein in cells over - expressing HO - 1 was 58% less than those expressing Myc - a - synuclein only. The relative amount of aggregated Myc - A30P, on the other hand, in cells over - expressing A30P and HO - 1 was 85% of that expressing Myc - A30P alone."
                },
                {
                    "Variant": "A30P",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "N.D.",
                    "Result Description": "The A30P mutation did not interfere with HO activity in cells. The proportion of live cells in A30P transfected cultures was 95% of that computed in the WT - transfected cells. The resistance of A30P to HO - 1 - induced degradation is not because of excessive A30P protein expression."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "The data were presented as mean ± SE. Statistical analyses were performed by one - way ANOVA followed by Newman - Keuls post hoc comparisons to assess significant main effects within groups. Statistical significance was set at p < 0.05."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Cell survival and immunoprecipitation",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "Cells seeded in 96 - well plate and transfected with indicated plasmid DNA",
                "Description": "Cells seeded in 96 - well plate and transfected with indicated plasmid DNA were used for MTT cell survival assay. For immunoprecipitation, flag - tagged HO - 1 was immunoprecipitated from lysates of cells co - transfected with Flag - HO - 1 and Myc - a - synuclein (WT) or Myc - a - synuclein (A30P)."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Neither a - synuclein (WT) nor A30P was detected in the immune complex from immunoprecipitation of HO - 1 and a - synuclein WT or A30P. The proportion of live cells in A30P transfected cultures was 95% of that computed in the WT - transfected cells in MTT cell survival assay."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "The data were presented as mean ± SE. Statistical analyses were performed by one - way ANOVA followed by Newman - Keuls post hoc comparisons to assess significant main effects within groups. Statistical significance was set at p < 0.05."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
